Bone metastases from solid tumors as osteolytic and/or osteoblastic.
Treatment of osteolytic lesions of multiple myeloma in combination with antineoplastic therapy.
Reduction of bone damage in patients with advanced malignancies involving bone.
Hypercalcemia of malignancy (HCM).
Other Services
Country
Account